"Bergstrom Eye Research is devoted to the efficient management of Phase II, III, and IV clinical trials. Our mission is to adhere to a teamwork model that fosters creativity and provides the highest level of ethical standards and quality results to patients and customers in a timely and efficient manner. We work in conjunction with Bergstrom Eye & Laser Clinic to provide opportunity to our customers and community in working to improve the quality of life. Bergstrom Eye Research provides quality care as one of the few devoted ophthalmology research sites in the Midwest."

During the past decade, Bergstrom Eye Research conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bergstrom Eye Research" #1 sponsor was "Clearside Biomedical, Inc." with 2 trials, followed by "Aciont Inc" with 1 trials sponsored, "Aerie Pharmaceuticals" with 1 trials sponsored, "Aldeyra Therapeutics, Inc." with 1 trials sponsored and "Kala Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bergstrom Eye Research" #1 collaborator was "National Eye Institute (NEI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Bergstrom Eye Research" are "Panuveitis" (2 trials), "Uveitis" (2 trials), "Uveitis, Anterior" (2 trials), "Uveitis, Intermediate" (2 trials) and "Uveitis, Posterior" (2 trials). Many other conditions were trialed in "Bergstrom Eye Research" in a lesser frequency.

Most popular intervention types in "Bergstrom Eye Research" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "0.005% Lacripep" (1 trials), "0.01% Lacripep" (1 trials), "15% Dexamethasone Sodium Phosphate - Visulex" (1 trials), "4 mg CLS-TA Suprachoriodal Injection" (1 trials) and "4mg CLS-TA Suprachoriodal Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bergstrom Eye Research" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Bergstrom Eye Research". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Bergstrom Eye Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bergstrom Eye Research, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".